BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Revance Announces Proposed Public Offering of $175M of Shares of Common Stock

  In addition, certain stockholders of the Company (the “Selling Stockholders”) are offering 600,000 shares of the Company’s common stock for sale to the public

  December 5, 2017

   · 

  4 min read
• Business

  Kewaunee Scientific Corp. Reports Results for Second Quarter

  Net earnings for the quarter increased 16.0% to $1,724,000, or $0.62 per diluted share, as compared to net earnings of $1,486,000, or $0.54 per diluted share, in the second quarter last year.

  December 5, 2017

   · 

  11 min read
• Biotech Beach

  Recent Multicenter JCM Publication Shows ESwab’s Versatility and Effectiveness in Detecting MRSA From Nasal Swabs on Cepheid’s Xpert MRSA Next Generation Assay

  The study is added proof to the mounting evidence that ESwab is a truly multipurpose and open platform swab sample collection system that once adopted by the laboratory, it makes it easier to implement the latest technology and tests.

  December 5, 2017

   · 

  3 min read
• Policy

  Sunovion Snags FDA OK for Lonhala Magnair Inhalation Solution to Treat COPD

  Sunovion expects LONHALA MAGNAIR to be available in U.S. pharmacies in early 2018.

  December 5, 2017

   · 

  16 min read
• Business

  Sekisui Diagnostics Enters Strategic Alliance With Mesa Biotech for Molecular POC Testing System

  Today, Sekisui Diagnostics and Mesa Biotech announce a strategic alliance, to distribute the Mesa Biotech POC molecular system for Flu A/Flu B.

  December 5, 2017

   · 

  3 min read
• Drug Development

  Neuralstem Presents Positive Updated Data from Phase II Study of NSI-189 in Major Depressive Disorder at the 56th American College of Neuropsychopharmacology (ACNP) Annual Meeting

  These additional results suggest that NSI-189 has antidepressant effects with cognitive benefits shown on both objective and subjective measures.

  December 5, 2017

   · 

  7 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center Release: Scientists Create Successful Mass Production System for Bioengineered Livers

  A team led by the Cincinnati Children’s CuSTOM and Yokohama City University in Japan report their findings Dec. 5 in Cell Reports.

  December 5, 2017

   · 

  4 min read
• Business

  Alderley Park’s Apconix Achieves Five-Fold Turnover Boost Via Pharma Sector Demand for Drug Safety Expertise

  Alderley Park-based ApconiX has achieved a five-fold sales increase in its second year of trading, far exceeding its predicted annual forecast.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Novo Nordisk: Xultophy Reported a Better Option Than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Participants in the DUAL VII Clinical Trial

  These results were presented today at the 2017 International Diabetes Federation Congress in Abu Dhabi, UAE.

  December 5, 2017

   · 

  5 min read
• Business

  Oxford Genetics Announces Adeno-Associated Virus Collaboration With MeiraGTx

  The collaboration will enable Oxford Genetics and MeiraGTx to develop novel AAV vectors, as well as packaging and producer cell lines.

  December 5, 2017

   · 

  2 min read